Pankreatitisprophylaxe nach ERCP – Indometacin senkt das Risiko signifikant

July 2012, Volume 7, Issue 4, pp 336–337 | Cite as

Für Sie gelesen

First Online: 29 June 2012

Prevention of pancreatitis after ERCP – Indomethacin provides a significant risk reduction

This is a preview of subscription content, to check access.

Der Autor gibt an, dass kein Interessenkonflikt besteht.

1.
Loperfido S, Costamagna G (2012) Post-ERCP pancreatitis; risk factors. UpToDate (http://www.uptodate.com/contents/post-ercp-pancreatitis)Google Scholar
2.
Katsinelos P, Fasoulas K, Paroutoglou G (2012) Combination of diclofenac plus somatostatin in the prevention of post-ERCP pancreatitis. Endoscopy 44: 53–59PubMedCrossRefGoogle Scholar
3.
Dumonceau J-M, Andriulli A, Deviere J (2010) European Society of Gastrointestinal Endoscopy (ESGE) Guideline: prophylaxis of post-ERCP pancreatitis. Endoscopy 42: 503–515PubMedCrossRefGoogle Scholar
4.
Mazaki T, Masuda H, Takayama T (2010) Prophylactic pancreatic stent placement and post-ERCP pancreatitis: asystematic review and meta-analysis. Endoscopy 42: 842–853PubMedCrossRefGoogle Scholar

1.Abteilung für Innere Medizin - GastroenterologieDRK-Krankenhaus ClementinenhausHannoverDeutschland